Ivacaftor FDA approval date

The FDA approved Ivacaftor on 31 Jan 2012.

FDA approval date
31 Jan 2012

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X AlleleNCT04126473ELOXPhase 2Completed2022-04-06Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2012-01-31DayIvacaftorFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA203188", "applicant_as_listed_by_fda": "VERTEX PHARMS", "brand_names": ["KALYDECO"], "active_ingredients": ["IVACAFTOR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120131", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026